Micropaque (Barium Sulfate)

Micropaque, a barium sulfate contrast agent, is used in radiographic imaging of the gastrointestinal tract.

• Barium swallow (esophageal imaging): provides clear visualization of the esophagus to detect strictures, motility disorders or lesions.
• Barium enema (colon imaging): outlines the colon and rectum for assessment of polyps, inflammation or structural abnormalities.
• Upper gastrointestinal tract radiography: delineates the stomach and duodenum to evaluate ulcers, tumors or functional disorders.

• Barium sulfate consists of insoluble, high‑density particles with a high atomic number that strongly absorb X‑rays. When administered orally or rectally, the suspension coats the lining of the gastrointestinal tract, creating a radiopaque barrier that reflects X‑ray beams. This contrast enhances the distinction between the lumen and surrounding tissues on radiographic images, allowing clinicians to visualize anatomical structures and detect abnormalities.

Barium sulfate suspension may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild feeling of queasiness after ingestion.
• Abdominal cramping: temporary discomfort in the stomach or intestines.
• Diarrhea: loose stools occurring within hours of administration.
• Constipation: difficulty passing bowel movements following the procedure.
• Vomiting: occasional expulsion of the contrast material.
• Taste disturbance: metallic or chalky sensation in the mouth.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling or anaphylaxis requiring immediate medical attention.
• Aspiration: inhalation of the suspension into the lungs leading to respiratory distress.
• Bowel perforation: rare tearing of the intestinal wall that may necessitate surgery.
• Severe electrolyte imbalance: significant shifts in blood minerals after large volume administration.

Before using Micropaque, healthcare professionals should observe several precautionary measures to ensure patient safety.

• Assess for bowel obstruction: confirm no known gastrointestinal blockage before administration.
• Verify hypersensitivity: inquire about previous allergic reactions to barium or similar contrast agents.
• Ensure adequate hydration: encourage fluid intake to facilitate passage of the suspension.
• Avoid use in suspected perforation: contraindicated when intestinal perforation is suspected.
• Use with caution in pregnancy: limited safety data; weigh diagnostic benefit against potential risk.
• Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Barium sulfate can affect the absorption or effectiveness of certain orally administered medications, requiring attention to possible drug interactions.

Major Interactions (Avoid)

• Tetracycline antibiotics: barium binds and markedly reduces absorption, compromising efficacy.
• Fluoroquinolone antibiotics: concurrent use may lower drug bioavailability.
• Iron supplements: barium interferes with iron absorption, diminishing therapeutic effect.

Moderate Interactions (Monitor Closely)

• Levothyroxine (thyroid hormone): barium may decrease absorption; monitor thyroid function tests.
• Other oral medications: timing of administration should be spaced at least 4 hours apart to avoid reduced uptake.